Opin vísindi

Cell Internalization in Fluidic Culture Conditions Is Improved When Microparticles Are Specifically Targeted to the Human Epidermal Growth Factor Receptor 2 (HER2)

Skoða venjulega færslu

dc.contributor Háskóli Íslands
dc.contributor University of Iceland
dc.contributor.author Mora-Espí, Inmaculada
dc.contributor.author Ibáñez, Elena
dc.contributor.author Soriano, Jorge
dc.contributor.author Nogués, Carme
dc.contributor.author Gudjonsson, Thorarinn
dc.contributor.author Barrios, Leonardo
dc.date.accessioned 2020-05-06T13:31:49Z
dc.date.available 2020-05-06T13:31:49Z
dc.date.issued 2019-04-11
dc.identifier.citation Mora-Espí, I.; Ibáñez, E.; Soriano, J.; Nogués, C.; Gudjonsson, T.; Barrios, L. Cell Internalization in Fluidic Culture Conditions Is Improved When Microparticles Are Specifically Targeted to the Human Epidermal Growth Factor Receptor 2 (HER2). Pharmaceutics 2019, 11, 177.
dc.identifier.issn 1999-4923
dc.identifier.uri https://hdl.handle.net/20.500.11815/1778
dc.description Publisher's version (útgefin grein)
dc.description.abstract Purpose: To determine if the specific targeting of microparticles improves their internalization by cells under fluidic conditions. Methods: Two isogenic breast epithelial cell lines, one overexpressing the Human Epidermal Growth Factor Receptor 2 (HER2) oncogene (D492HER2) and highly tumorigenic and the other expressing HER2 at much lower levels and non-tumorigenic (D492), were cultured in the presence of polystyrene microparticles of 1 _m in diameter, biofunctionalized with either a specific anti-HER2 antibody or a non-specific secondary antibody. Mono- and cocultures of both cell lines in static and fluidic conditions were performed, and the cells with internalized microparticles were scored. Results: Globally, the D492 cell line showed a higher endocytic capacity than the D492HER2 cell line. Microparticles that were functionalized with the anti-HER2 antibody were internalized by a higher percentage of cells than microparticles functionalized with the non-specific secondary antibody. Although internalization was reduced in fluidic culture conditions in comparison with static conditions, the increase in the internalization of microparticles biofunctionalized with the anti-HER2 antibody was higher for the cell line overexpressing HER2. Conclusion: The biofunctionalization of microparticles with a specific targeting molecule remarkably increases their internalization by cells in fluidic culture conditions (simulating the blood stream). This result emphasizes the importance of targeting for future in vivo delivery of drugs and bioactive molecules through microparticles.
dc.description.sponsorship This research was funded by the Spanish Ministerio de Ciencia e Innovación (MAT2014-57960-C3-3-R and MAT2017-86357-C3-3-R) and the Generalitat de Catalunya (2017-SGR-503). I.M.E. Thanks to the Spanish Ministerio de Ciencia e Innovación for a predoctoral grant.
dc.format.extent 177
dc.language.iso en
dc.publisher MDPI AG
dc.relation.ispartofseries Pharmaceutics;11(4)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Biofunctionalization
dc.subject Coculture
dc.subject HER2
dc.subject Microfluidics
dc.subject Polystyrene μPs
dc.subject Frumurannsóknir
dc.subject lyfja
dc.title Cell Internalization in Fluidic Culture Conditions Is Improved When Microparticles Are Specifically Targeted to the Human Epidermal Growth Factor Receptor 2 (HER2)
dc.type info:eu-repo/semantics/article
dcterms.license This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
dc.description.version Peer Reviewed
dc.identifier.journal Pharmaceutics
dc.identifier.doi 10.3390/pharmaceutics11040177
dc.relation.url https://www.mdpi.com/1999-4923/11/4/177/pdf
dc.contributor.department Læknadeild (HÍ)
dc.contributor.department Faculty of Medicine (UI)
dc.contributor.department Biomedical Center (UI)
dc.contributor.department Lífvísindasetur (HÍ)
dc.contributor.school Heilbrigðisvísindasvið (HÍ)
dc.contributor.school School of Health Sciences (UI)


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu